micol eleonora fiori
National Institute of Health (ISS)
Rome, Italy
Community Reviewer
Molecular Medicine and Cancer Treatment
National Institute of Health (ISS)
Rome, Italy
Community Reviewer
Molecular Medicine and Cancer Treatment
INSERM U1192 Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM)
Villeneuve-d'Ascq, France
Community Reviewer
Molecular Medicine and Cancer Treatment
Xiangya Hospital, Central South University
Changsha, China
Community Reviewer
Molecular Medicine and Cancer Treatment
Nanjing Drum Tower Hospital
Nanjing, China
Community Reviewer
Molecular Medicine and Cancer Treatment
National Institute of Neurological Disorders and Stroke (NIH)
Bethesda, United States
Community Reviewer
Molecular Medicine and Cancer Treatment
University of Illinois Chicago
Chicago, United States
Community Reviewer
Molecular Medicine and Cancer Treatment
University of Bristol
Bristol, United Kingdom
Community Reviewer
Molecular Medicine and Cancer Treatment
Istituto di Bioimmagini e Sistemi Biologici Complessi (IBSBC-CNR)
Milan, Italy
Community Reviewer
Molecular Medicine and Cancer Treatment
University of Galway
Galway, Ireland
Community Reviewer
Molecular Medicine and Cancer Treatment
Institute of Molecular Biology and Biophysics FRC FTM
Novosibirsk, Russia
Community Reviewer
Molecular Medicine and Cancer Treatment
UmeĂĄ University
UmeĂĄ, Sweden
Community Reviewer
Molecular Medicine and Cancer Treatment
Cardiff University
Cardiff, United Kingdom
Community Reviewer
Molecular Medicine and Cancer Treatment
Jiangsu Province Geriatric Hospital
Nanjing, China
Community Reviewer
Molecular Medicine and Cancer Treatment
Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University
Okayama, Japan
Community Reviewer
Molecular Medicine and Cancer Treatment
Soochow University
Suzhou, China
Community Reviewer
Molecular Medicine and Cancer Treatment
Swansea University Medical School
Swansea, United Kingdom
Community Reviewer
Molecular Medicine and Cancer Treatment